Access to medicines is a global struggleSubscription
A range of measures can be employed to improve access to medicines in developing countries, but there is no simple solution.
Anoro Ellipta, a novel inhaler containing a long-acting muscarinic receptor antagonist and a selective long-acting beta-2 adrenergic receptor agonist, may find a limited place in therapy.
NICE recommends two point-of-care coagulometers for use by patients – Roche Diagnostic’s CoaguChek XS system and Alere’s INRatio2 PT/INR monitor.
Nepal adopts inactivated polio vaccineSubscription
New melanoma treatment approved by NICESubscription
News in Brief
Ebola trials fast-tracked in Africa Subscription
New approach to target antimicrobial resistanceSubscription
Memory slips associated with dementia riskSubscription